Insmed
INSM
#981
Rank
โ‚น2.319 T
Marketcap
โ‚น10,621
Share price
15.07%
Change (1 day)
-27.99%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -โ‚น71.39 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น1.13 Billion. In 2025 the company made an earning of -โ‚น113.67 Billion a decrease over its 2024 earnings that were of -โ‚น78.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น71.39 Billion-37.2%
2025 -โ‚น113.67 Billion43.91%
2024 -โ‚น78.99 Billion23.71%
2023 -โ‚น63.85 Billion45.77%
2022 -โ‚น43.8 Billion15.83%
2021 -โ‚น37.82 Billion50.19%
2020 -โ‚น25.18 Billion16.4%
2019 -โ‚น21.63 Billion-23.9%
2018 -โ‚น28.43 Billion59.35%
2017 -โ‚น17.84 Billion8.52%
2016 -โ‚น16.44 Billion47.25%
2015 -โ‚น11.17 Billion34.53%
2014 -โ‚น8.3 Billion58.83%
2013 -โ‚น5.23 Billion35.14%
2012 -โ‚น3.87 Billion-31.92%
2011 -โ‚น5.68 Billion854.92%
2010 -โ‚น0.6 Billion-105.22%
2009 โ‚น11.38 B-905.06%
2008 -โ‚น1.42 Billion-27.31%
2007 -โ‚น1.95 Billion-62.41%
2006 -โ‚น5.18 Billion98.19%
2005 -โ‚น2.62 Billion0.03%
2004 -โ‚น2.62 Billion159.07%
2003 -โ‚น1.01 Billion-69.31%
2002 -โ‚น3.29 Billion
2000 -โ‚น2.97 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.477 T-2,056.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
-โ‚น186.08 Billion 146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น480.07 B-735.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น12.47 Billion-83.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.22 Billion-97.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-โ‚น4.92 Billion-93.49%๐Ÿ‡บ๐Ÿ‡ธ USA